TrialBMC gastroenterology2011

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam).

Federico Coccolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.